|
2025
|
G/S
|
Pharmaceutical preparations; Medicinal healthcare preparations; drugs for medical purposes; Diagn... |
|
|
G/S
|
(Based on 44(e))(Based on 44(d) Priority Application) Scientific laboratory services; agricultura... |
|
|
G/S
|
Fresh fruits and vegetables; Fresh herbs; natural plants and flowers; Agricultural and horticultu... |
|
|
G/S
|
Scientific apparatus and instruments; Research apparatus and instruments. Raw and unprocessed agr... |
|
|
G/S
|
Scientific services and design relating thereto; Technological services and research relating the... |
|
|
Invention
|
Yeast for increased lipid production. Yarrowia lipolytica Y. lipolyticaY. lipolyticaY. lipolytica... |
|
|
Invention
|
De novo design of antibodies targeting a specific epitope. The present invention relates to metho... |
|
|
Invention
|
Means and methods for displaying fc-containing proteins on cells and selection thereof. The inven... |
|
|
Invention
|
Human beta-glucocerebrosidase binders and uses thereof. This application relates to polypeptide a... |
|
|
Invention
|
Binding constructs. inter alia inter alia a construct comprising a FAP binding agent and an LTBR ... |
|
|
Invention
|
Means and methods for the production of saponins with endosomal escape-enhancing properties. This... |
|
|
Invention
|
Means and methods for the induction of protein degradation. The invention provides means and meth... |
|
|
Invention
|
Targeted modified tnf family members.
The present invention relates to a modified cytokine of th... |
|
|
Invention
|
Means and methods for the production of woody plants with altered lignin composition. The present... |
|
2024
|
Invention
|
Potassium channel activators and their use in treating disorders involving hyperexcitability. The... |
|
|
Invention
|
Transmembrane beta barrels. The present invention relates to a transmembrane beta barrel polypept... |
|
|
Invention
|
Means and methods to classify the gut microbiome. The present invention relates to the field of t... |
|
|
Invention
|
Antibodies against influenza b virus. The invention relates to antigen-binding polypeptides speci... |
|
|
G/S
|
Science and technology services, namely, scientific and technological research in the field of ph... |
|
|
G/S
|
(Based on 44(e) Priority Application) Pharmaceutical preparations and substances, namely, pharmac... |
|
|
Invention
|
Monitoring of a hemodynamic parameter. The invention relates to methods of processing of Doppler ... |
|
|
Invention
|
Binding domains directed against gpcr:g protein complexes and uses derived thereof.
The present ... |
|
|
Invention
|
Optimized sarbecovirus spike s2 subunit binders and compositions comprising the same. This invent... |
|
|
Invention
|
Hematopoietic prostaglandin synthase (hpgds) inhibition for treating cancer. The disclosure relat... |
|
|
Invention
|
Inhibition of prostaglandin d2 receptor 2 as means for treating cancer. The disclosure relates to... |
|
|
Invention
|
Inhibition of prostaglandin d2 receptor 1 as means for treating cancer. The disclosure relates to... |
|
|
Invention
|
Sble mutants with altered activity and sble homologues. S.SSS.S.SS.S.S. bombicola SBLE enzyme and... |
|
|
Invention
|
Methods of determining response of a tumor to dna-damaging agents or to agents inhibiting or impa... |
|
|
Invention
|
Method of detecting loss of heterozygosity status of a tumor. This disclosure relates to methods ... |
|
|
Invention
|
Multispecific antibodies for neurological disorders. The invention relates to multispecific polyp... |
|
|
Invention
|
Alpha-helical protein nanofibrils. The present invention relates to the field of microbial self-a... |
|
|
Invention
|
Novel protein pores.
The present invention relates to novel protein pores and their uses in anal... |
|
|
Invention
|
Novel binders targeting the multi-drug resistant pathogen acinetobacter baumannii. Acinetobacter ... |
|
|
Invention
|
Chimeric proteins for modulating cytokine receptor activity. The present invention belongs to the... |
|
|
Invention
|
2-pyrazole anilines and related analogs for inhibiting yap/taz-tead.
The present disclosure rela... |
|
|
Invention
|
Glyco-engineered antibody-drug-conjugates comprising an oxime linker. The present invention relat... |
|
|
Invention
|
Use of intra-tumoral cd8 temra cells for predicting response of a cancer patient to checkpoint in... |
|
|
Invention
|
Novel plant growth promoting bradyrhizobium compositions. The present invention relates to the fi... |
|
|
Invention
|
Transmembrane pore consisting of two csgg pores.
Provided is a method of characterising a polynu... |
|
|
Invention
|
Tetrahydronapthyridine and related analogs for inhibiting yap/taz-tead.
The present disclosure r... |
|
|
Invention
|
Benzimidazole and related analogs for inhibiting yap/taz-tead.
The present disclosure relates to... |
|
|
Invention
|
Benzimidazole and related analogs for inhibiting yap/taz-tead. The present disclosure relates to ... |
|
|
Invention
|
Tetrahydronapthyridine and related analogs for inhibiting yap/taz-tead. The present disclosure re... |
|
|
Invention
|
Means and methods for single molecule peptide sequencing. The present invention relates to the fi... |
|
2023
|
Invention
|
Improved microfluidic chip, system and method for protein purification.
The current invention re... |
|
|
Invention
|
Sarbecovirus spike s2 subunit binders.
Sarbecovirus binding agents, in particular antibodies and... |
|
|
Invention
|
Prevention and treatment of infections with intracellular bacteria.
The present invention relate... |
|
|
Invention
|
Liver-specific nucleic acid regulatory elements and methods and use thereof. Described are nuclei... |
|
|
Invention
|
An ltbr agonist in combination therapy against cancer.
The present invention relates to a combin... |
|
|
G/S
|
Pharmaceutical, medical and veterinary preparations and substances; diagnostics and therapeutic p... |
|
|
G/S
|
Pharmaceutical preparations and substances, namely, pharmaceutical preparations for the treatment... |
|
|
Invention
|
Methods and applications of analyzing the perfusate of an ex situ perfused kidney.
The invention... |
|
|
Invention
|
Improved probiotic potency of the yeast saccharomyces boulardii.
The present invention relates t... |
|
2022
|
Invention
|
Glyco-engineered car-t cells.
The invention relates to the field of CAR-T cell immunotherapy, mo... |
|
|
G/S
|
Pharmaceutical preparations and substances, namely, biotherapeutics for targeted protein degradat... |
|
|
Invention
|
Improved gamma-secretase inhibitor screening assays.
Current application relates to the field of... |
|
|
Invention
|
Means and methods for chronic wound healing.
The present invention relates to the field of tissu... |
|
|
Invention
|
Crystal structures of alk and ltk receptor tyrosine kinases and their ligands.
The present inven... |
|
|
Invention
|
Means and methods to regulate gut dysbiosis.
The present invention relates to the field of micro... |
|
|
Invention
|
Cation-independent mannose-6-phosphate receptor binders.
The present invention relates to protei... |
|
2020
|
G/S
|
Proteins for use in drug discovery and structural biology, namely, proteins, protein conjugates, ... |
|
|
G/S
|
Pharmaceutical and veterinary products. Scientific and technological services and research and
d... |
|
2019
|
G/S
|
Medical and veterinary preparations and articles; diagnostic preparations and materials; pharmace... |
|
|
G/S
|
Pharmaceuticals and natural remedies; Medicines for veterinary purposes; Pharmaceutical preparati... |
|
2010
|
G/S
|
Research and development in the field of neuroscience and neuroelectronics |
|
|
G/S
|
Research and development in the field of neuroscience and
neuroelectronics. |
